TELMISARTAN for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 5 adverse event reports in the FDA FAERS database where TELMISARTAN was used for Psoriasis.
Most Reported Side Effects for TELMISARTAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 685 | 11.5% | 43 | 171 |
| Dizziness | 569 | 9.6% | 224 | 116 |
| Dyspnoea | 556 | 9.3% | 224 | 132 |
| Headache | 508 | 8.5% | 219 | 99 |
| Fall | 500 | 8.4% | 225 | 248 |
| Nausea | 486 | 8.2% | 181 | 131 |
| Hypertension | 477 | 8.0% | 32 | 138 |
| Blood pressure increased | 473 | 8.0% | 189 | 107 |
| Diarrhoea | 467 | 7.8% | 237 | 121 |
| Malaise | 458 | 7.7% | 187 | 148 |
| Fatigue | 445 | 7.5% | 199 | 149 |
| Arthralgia | 433 | 7.3% | 218 | 70 |
| Asthenia | 418 | 7.0% | 188 | 85 |
| Cough | 361 | 6.1% | 183 | 52 |
| Pruritus | 340 | 5.7% | 214 | 46 |
Other Indications for TELMISARTAN
Product used for unknown indication (2,724)
Hypertension (2,338)
Essential hypertension (67)
Blood pressure measurement (66)
Blood pressure abnormal (53)
Cardiac failure (30)
Blood pressure increased (25)
Blood pressure management (25)
Glaucoma (25)
Myocardial infarction (22)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)